chemistry is a living thing. it’s constantly evolving and changing. the chemours company focuses on applying the power of chemistry to shape markets, redefine industries and change lives. chemours was created from dupont's performance chemicals businesses. we are a world leader in titanium technologies, fluoroproducts and chemical solutions. we're also a company of firsts, constantly changing the formula for what chemistry can do. consider these transformative product innovations: • ti-pure™ one coat technology and market understanding enables paint formulations that cover more, with less paint and less effort • opteon™ yf refrigerants for auto air conditioning systems have a global warming potential that is 99.9% lower than the current alternative, hfc-134a • teflon ecoelite™ finish, new to the market in 2016, is the first renewably sourced, non-fluorinated fabric treatment for durable water repellency; containing 60% renewably sourced raw material it repels water and water-based stai
Company profile
Ticker
CC, CC-MM
Exchange
Website
CEO
Mark Vergnano
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Huntsman • FMC • Ecovyst • Olin • Perimeter Solutions • GCP Applied • Innospec • Ingevity • Livent • Balchem ...
Former names
Chemours Company, LLC
SEC CIK
Corporate docs
Subsidiaries
2463297 Ontario Limited • Chemours Belgium BVBA • Chemours Deutschland GmbH • Chemours France SAS • Chemours Hong Kong Holding Limited • Chemours International Operations • Chemours Italy S.r.l. • Chemours Korea Inc. • Chemours Netherlands B.V. • Chemours NL Holding 1 B.V. ...
CC stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
25 Apr 24
ARS
2023 FY
Annual report to shareholders
11 Apr 24
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
8-K
Regulation FD Disclosure
28 Mar 24
8-K
Chemours Announces Completion of Planned Procedures by the Audit Committee with Respect to Internal Review
27 Mar 24
8-K
The Chemours Company Reports Fourth Quarter and Full Year 2023 Results
27 Mar 24
10-K
2023 FY
Annual report
27 Mar 24
8-K
2023 Form 10-K Filing and Webcast Conference Call
26 Mar 24
8-K
Chemours Announces Appointment of Denise Dignam as President
25 Mar 24
Transcripts
CC
Earnings call transcript
2023 Q4
28 Mar 24
CC
Earnings call transcript
2023 Q3
27 Oct 23
CC
Earnings call transcript
2023 Q2
28 Jul 23
CC
Earnings call transcript
2023 Q1
28 Apr 23
CC
Earnings call transcript
2022 Q4
10 Feb 23
CC
Earnings call transcript
2022 Q3
26 Oct 22
CC
Earnings call transcript
2022 Q2
29 Jul 22
CC
Earnings call transcript
2022 Q1
3 May 22
CC
Earnings call transcript
2021 Q4
11 Feb 22
CC
Earnings call transcript
2021 Q3
5 Nov 21
Latest ownership filings
3/A
Diane I. Picho
1 Apr 24
3
Diane I. Picho
29 Mar 24
4
Alvenia Scarborough
29 Mar 24
4
Matthew S Abbott
29 Mar 24
4
Denise Dignam
29 Mar 24
4/A
Alvenia Scarborough
6 Mar 24
4
Kristine M Wellman
5 Mar 24
4
Alvenia Scarborough
5 Mar 24
4
Joseph T. Martinko
5 Mar 24
4
Calderon Gerardo Familiar
5 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.45 bn | 1.45 bn | 1.45 bn | 1.45 bn | 1.45 bn | 1.45 bn |
Cash burn (monthly) | (no burn) | (no burn) | 12.00 mm | 28.00 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 82.58 mm | 192.69 mm | n/a | n/a |
Cash remaining | n/a | n/a | 1.36 bn | 1.25 bn | n/a | n/a |
Runway (months of cash) | n/a | n/a | 113.7 | 44.8 | n/a | n/a |
Institutional ownership, Q4 2023
53.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 359 |
Opened positions | 57 |
Closed positions | 146 |
Increased positions | 81 |
Reduced positions | 124 |
13F shares | Current |
---|---|
Total value | 2.37 tn |
Total shares | 79.31 mm |
Total puts | 652.70 k |
Total calls | 288.30 k |
Total put/call ratio | 2.3 |
Largest owners | Shares | Value |
---|---|---|
FMR | 16.44 mm | $518.63 bn |
Vanguard | 16.03 mm | $505.52 bn |
BK Bank Of New York Mellon | 5.79 mm | $182.53 bn |
Massachusetts Financial Services | 4.76 mm | $150.24 bn |
STT State Street | 4.51 mm | $142.35 bn |
Marshall Wace | 3.91 mm | $123.38 bn |
JPM JPMorgan Chase & Co. | 3.54 mm | $111.52 bn |
Dimensional Fund Advisors | 2.55 mm | $80.34 bn |
American Century Companies | 1.43 mm | $45.00 bn |
Vaughan Nelson Investment Management | 1.38 mm | $43.58 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Mar 24 | Alvenia Scarborough | Common Stock | Payment of exercise | Dispose F | No | No | 28.88 | 1,781 | 51.44 k | 23,839.976 |
27 Mar 24 | Alvenia Scarborough | Common Stock | Grant | Acquire A | No | No | 0 | 5,276 | 0.00 | 25,620.976 |
27 Mar 24 | Matthew S Abbott | Common Stock | Payment of exercise | Dispose F | No | No | 28.88 | 2,039 | 58.89 k | 34,288.225 |
27 Mar 24 | Matthew S Abbott | Common Stock | Grant | Acquire A | No | No | 0 | 6,331 | 0.00 | 36,327.225 |
27 Mar 24 | Denise Dignam | Common Stock | Payment of exercise | Dispose F | No | No | 28.88 | 3,058 | 88.32 k | 40,896.797 |
27 Mar 24 | Denise Dignam | Common Stock | Grant | Acquire A | No | No | 0 | 9,496 | 0.00 | 43,954.797 |
News
Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields
16 Apr 24
Why Chemours Gets A Double Upgrade From This Analyst
9 Apr 24
BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34
9 Apr 24
Peering Into Chemours's Recent Short Interest
4 Apr 24
UBS Maintains Neutral on Chemours, Raises Price Target to $28
2 Apr 24
Press releases
ROSEN, LEADING INVESTOR COUNSEL, Encourages The Chemours Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - CC
25 Apr 24
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against The Chemours Company (CC)
25 Apr 24
THE CHEMOURS COMPANY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Chemours Company - CC
24 Apr 24
Chemours Announces Dates for First Quarter 2024 Earnings Release and Webcast Conference Call
24 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company - CC
24 Apr 24